The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Better compliance to antihypertensive medications reduces cardiovascular risk
Abstract
OBJECTIVE: The effect of compliance with antihypertensive medications on the risk of cardiovascular outcomes in a population without a known history of cardiovascular disease has been addressed by a large population-based prospective, cohort study carried out by linking Italian administrative databases. METHODS: The cohort of 242 594 patients aged 18 years or older, residents in the Italian Lombardy Region, who were newly treated for hypertension during 2000-2001, was followed from index prescription until 2007. During this period patients who experienced a hospitalization for coronary or cerebrovascular disease were identified (outcome). Exposure to antihypertensive drugs from index prescription until the date of hospitalization or censoring was assessed. Proportional hazards models were fitted to assess the association between persistence on and adherence with antihypertensive drug therapy and outcome. Data were adjusted for several covariates. RESULTS: During an average follow-up of 6 years, 12 016 members of the cohort experienced the outcome. Compared with patients who experienced at least one episode of treatment discontinuation, those who continued treatment had a 37% reduced risk of cardiovascular outcomes (95% confidence interval 34-40%). Compared with patients who had very low drug coverage (proportion of days covered ≤ 25%), those at intermediate (from 51 to 75%) and high coverage (>75%) had risk reductions of 20% (16-24%) and 25% (20-29%), respectively. Similar effects were observed when coronary and cerebrovascular events were considered separately. CONCLUSIONS: In the real life setting, fulfillment compliance with antihypertensive medications is effective in the primary prevention of cardiovascular outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence to antihypertensive treatment affects 10%-80% of hypertensive patients and is one of the key drivers of suboptimal BP control. 75-77”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [77]
In the citing paper
“and it is associated with an increased risk of cardiovascular events [45].”
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationDiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Worldwide prevalence of hypertension: a systematic review
Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K., & He, J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200401000-00003 · Cited by 1,140
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Self-citation2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
Burnier, M., & Egan, B. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313220 · Cited by 878
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
“For hypertension (and other chronic diseases), investigating adherence to treatment is now facilitated by electronic methods of measuring adherence and by the availability of administrative databases that provide information for the entire population [709,711].”
BackgroundMancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
“adherence and by the availability of administrative databases that provide information for the entire population.(709,711) Several approaches have been proposed to reduce physician”
BackgroundSelf-citationTomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., Samani, N. J., Gupta, P., Madira, W., Stanley, A., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305063 · Cited by 404
for the ABC project team, Demonceau, J., Ruppar, T., Kristanto, P., Hughes, D. A., Fargher, E., Kardas, P., De Geest, S., Dobbels, F., Lewek, P., et al. (2013) · Drugs · doi:10.1007/s40265-013-0041-3 · Cited by 307
Current Situation of Medication Adherence in Hypertension
Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00100 · Cited by 292
“Persistence with antihypertensive treatment significantly reduces long-term cardiovascular risk (Corrao et al., 2011).”
BackgroundInfluentialParati, G., Kjeldsen, S., Coca, A., Cushman, W. C., & Wang, J. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.15781 · Cited by 281
Short- and Long-Term Blood Pressure Variability: Present and Future
Mancia, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194340 · Cited by 258
Self-citationBitton, A., Choudhry, N. K., Matlin, O. S., Swanton, K., & Shrank, W. H. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.09.004 · Cited by 256
Measuring, Analyzing, and Managing Drug Adherence in Resistant Hypertension
Burnier, M., Wuerzner, G., Struijker-Boudier, H., & Urquhart, J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00687 · Cited by 229
The Great East Japan Earthquake Disaster and cardiovascular diseases
Aoki, T., Fukumoto, Y., Yasuda, S., Sakata, Y., Ito, K., Takahashi, J., Miyata, S., Tsuji, I., & Shimokawa, H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs288 · Cited by 205
Berra, E., Azizi, M., Capron, A., Høieggen, A., Rabbia, F., Kjeldsen, S. E., Staessen, J. A., Wallemacq, P., & Persu, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07464 · Cited by 195
Lee, E. K. P., Poon, P., Yip, B. H. K., Bo, Y., Zhu, M., Yu, C., Ngai, A. C. H., Wong, M. C. S., & Wong, S. Y. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026582 · Cited by 178
Parati, G., Stergiou, G. S., Bilo, G., Kollias, A., Pengo, M., Ochoa, J. E., Agarwal, R., Asayama, K., Asmar, R., Burnier, M., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002922 · Cited by 178
“com/HJH/B683) Low adherence to antihypertensive medications is the most commoncauseof treatment resistance [44] and it is associated with an increased riskof cardiovascular events [45].”
Self-citationKim, S., Shin, D. W., Yun, J. M., Hwang, Y., Park, S. K., Ko, Y.-J., & Cho, B. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06731 · Cited by 174
Meyer, J. C., Schellack, N., Stokes, J., Lancaster, R., Zeeman, H., Defty, D., Godman, B., & Steel, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00751 · Cited by 175
de Oliveira-Filho, A. D., Morisky, D. E., Neves, S. J. F., Costa, F. A., & de Lyra, D. P. (2014) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2013.10.006 · Cited by 171
Hamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s368784 · Cited by 170
Medication adherence in hypertension
Poulter, N. R., Borghi, C., Parati, G., Pathak, A., Toli, D., Williams, B., & Schmieder, R. E. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002294 · Cited by 164
“reduced the risk of cardiovascular outcomes by 37% [13] and reduced the risk of hospitalization because of heart failure [14].”
BackgroundŠtrauch, B., Petrák, O., Zelinka, T., Rosa, J., Šomlóová, Z., Indra, T., Chytil, L., Marešová, V., Kurcová, I., Holaj, R., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283652c61 · Cited by 163
World Heart Federation Roadmap for Hypertension – A 2021 Update
Jeemon, P., Séverin, T., Amodeo, C., Balabanova, D., Campbell, N. R. C., Gaiță, D. I., Kario, K., Khan, T., Melifonwu, R., Moran, A. E., et al. (2021) · Global Heart · doi:10.5334/gh.1066 · Cited by 173
Drug adherence in hypertension
Burnier, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.015 · Cited by 175
Two-Drug Combinations as First-Step Antihypertensive Treatment
Mancia, G., Rea, F., Corrao, G., & Grassi, G. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313294 · Cited by 144
Self-citationPouls, B. P. H., Vriezekolk, J. E., Bekker, C. L., Linn, A. J., van Onzenoort, H. A. W., Vervloet, M., van Dulmen, S., & van den Bemt, B. J. F. (2021) · Journal of Medical Internet Research · doi:10.2196/18901 · Cited by 123
“Presumably 50% of all patients with long-term medication are nonadherent, leading to suboptimal treatment outcomes [2,3].”
BackgroundYang, Q., Chang, A., Ritchey, M. D., & Loustalot, F. V. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006056 · Cited by 146
Parati, G., Lombardi, C., Pengo, M. F., Bilo, G., & Ochoa, J. E. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.01.070 · Cited by 133
Rea, F., Corrao, G., Merlino, L. G., & Mancia, G. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11308 · Cited by 139
Self-citationDrug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111
Generating Evidence From Computerized Healthcare Utilization Databases
Corrao, G., & Mancia, G. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04858 · Cited by 114
Self-citationRea, F., Corrao, G., Merlino, L. G., & Mancia, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy420 · Cited by 106
Self-citationDigital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 109
Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health
Venditti, V., Bleve, E., Morano, S., & Filardi, T. (2023) · Metabolites · doi:10.3390/metabo13101087 · Cited by 134
“A large Italian prospective study showed that adherent patients had a 37% reduced risk of CV and cerebrovascular events compared to patients interrupting treatment over a six-year period [124].”
BackgroundCombination pharmacotherapy to prevent cardiovascular disease: present status and challenges
Working Group on the Summit on Combination Therapy for CVD (2013) · European Heart Journal · doi:10.1093/eurheartj/eht407 · Cited by 95
Xu, Y., Zheng, X., Li, Y., Ye, X., Cheng, H., Wang, H., & Lyu, J. (2023) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12548 · Cited by 113
Kim, Y.-Y., Lee, J.-S., Kang, H.-J., & Park, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30740-y · Cited by 109
Nashilongo, M. M., Singu, B., Kalemeera, F., Mubita, M., Naikaku, E., Baker, A., Ferrario, A., Godman, B., Achieng, L., & Kibuule, D. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6756-8 · Cited by 87
Patterns of hypertension management in France in 2015: The ESTEBAN survey
Vallée, A., Gabet, A., Grave, C., Sorbets, E., Blacher, J., & Olié, V. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13834 · Cited by 100
Hameed, M. A., Tebbit, L., Jacques, N., Thomas, M., & Dasgupta, I. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.38 · Cited by 89
Corrao, G., Mazzola, P., Compagnoni, M. M., Rea, F., Merlino, L., Annoni, G., & Mancia, G. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0306-5 · Cited by 76
“elsewhere [30–34].”
Self-citationBurnier, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01540 · Cited by 89
“Figure 1 illustrates one example of the relationship between adherence to antihypertensive therapy and the risk of coronary and cerebrovascular events in 445,356 patients from the Lombardy database (Corrao et al., 2011).”
BackgroundMancia, G., Zambon, A., Soranna, D., Merlino, L. G., & Corrao, G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000222 · Cited by 90
Self-citationKrousel-Wood, M. A., Holt, E. W., Joyce, C., Ruiz, R. L., Dornelles, A. C., Webber, L. S., Morisky, D. E., Frohlich, E. D., Ré, R. N., He, J., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000382 · Cited by 97
Schmieder, R. E., Ott, C., Schmid, A., Friedrich, S., Kistner, I., Ditting, T., Veelken, R. A., Uder, M., & Toennes, S. W. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002343 · Cited by 78
Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice
Corrao, G., Rea, F., Ghirardi, A., Soranna, D., Merlino, L. G., & Mancia, G. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05463 · Cited by 82
Self-citationAdherence to Antihypertensive Medications and Stroke Risk: A Dose‐Response Meta‐Analysis
Xu, T., Yu, X., Ou, S., Liu, X., Yuan, J., Tan, X., & Chen, Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006371 · Cited by 79
Nguyen, T.-P.-L., Schuiling‐Veninga, C. C. M., Nguyen, T. B. Y., Vu, T.-H., Wright, E. P., & Postma, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171203 · Cited by 67
Blood pressure control in hypertension. Pros and cons of available treatment strategies
Mancia, G., Rea, F., Cuspidi, C., Grassi, G. M., & Corrao, G. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001181 · Cited by 62
Self-citationLimited reproducibility of MUCH and WUCH: evidence from the ELSA study
Mancia, G., Facchetti, R., Cuspidi, C., Bombelli, M., Corrao, G., & Grassi, G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz651 · Cited by 53
Self-citationRea, F., Pagan, E., Compagnoni, M. M., Cantarutti, A., Pugni, P., Bagnardi, V., & Corrao, G. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/12616 · Cited by 57
Self-citationCoca, A., Agabiti‐Rosei, E., Cífková, R., Manolis, A. J., Redón, J., & Mancia, G. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001390 · Cited by 72
Self-citationMcCormack, T., Boffa, R. J., Jones, N. R., Carville, S. F., & McManus, R. J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz681 · Cited by 61
“The ESC/ESH recommendations for initial single pill combinations were justified by evidence of improved adherence (8, 9).”
BackgroundA systematic review of quantitative bias analysis applied to epidemiological research
Petersen, J. M., Ranker, L. R., Barnard‐Mayers, R., MacLehose, R. F., & Fox, M. P. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab061 · Cited by 69
Wong, M. C. S., Tam, W., Cheung, C. S. K., Wang, H., Tong, E. L. H., Sek, A. C. H., Yan, B. P.-Y., Cheung, N. T., Leeder, S., Yu, C., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.048 · Cited by 56
Lindblad, U., Ek, J., Eckner, J., Larsson, C., Shan, G., & Råstam, L. (2012) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2012.684207 · Cited by 59
“Though patients ’ compliance is discussed as a signifi cant issue [27,28], major responsibility has to be put on the health care and educational systems.”
BackgroundBerhe, D. F., Taxis, K., Haaijer‐Ruskamp, F. M., Mulugeta, A., Mengistu, Y. T., Burgerhof, J. G. M., & Mol, P. G. M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13312 · Cited by 47
Medical treatment of stable angina: A tailored therapeutic approach
Manolis, A. J., Poulimenos, L. E., Ambrosio, G., Kallistratos, M. S., López-Sendón, J., Dechend, R., Mancia, G., & Camm, A. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.150 · Cited by 54
Self-citationKobalava, Z. D., Конради, А. О., Nedogoda, S. V., Arutyunov, G. P., Баранова, Е. И., Барбараш, О. Л., Вадимовна, В. С., Galyavich, A. S., Глезер, М. Г., Drapkina, O. M., et al. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-12-131-142 · Cited by 52
Rossi, M., Carioli, G., Bonifazi, M., Zambelli, A., Franchi, M., Moja, L., Zambon, A., Corrao, G., Vecchia, C. L., Zocchetti, C., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.012 · Cited by 46
Self-citationMancia, G., Cappuccio, F. P., Burnier, M., Coca, A., Persu, A., Borghi, C., Kreutz, R. H., & Sanner, B. M. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13678 · Cited by 67
Self-citationTrastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Bonifazi, M., Franchi, M., Rossi, M., Moja, L., Zambelli, A., Zambon, A., Corrao, G., Vecchia, C. L., Zocchetti, C., & Negri, E. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0065 · Cited by 45
Self-citationMedication Non-adherence: a Major Cause of Resistant Hypertension
Hamrahian, S. M. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01400-3 · Cited by 69
Shen, Y., Peng, X., Wang, M., Zheng, X., Xu, G., Lü, L., Xu, K., Burström, B., Burström, K., & Wang, J. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.8 · Cited by 56
Hirakawa, Y., Arima, H., Webster, R. J., Zoungas, S., Li, Q., Harrap, S. B., Lisheng, L., Hamet, P., Mancia, G., Poulter, N. R., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000841 · Cited by 47
Self-citationMancia, G., Asmar, R. G., Amodeo, C., Mourad, J., Taddei, S., Gamba, M. A. A., Chazova, I. E., & Puig, J. G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000409 · Cited by 48
Self-citationProtective effects of antihypertensive treatment in patients aged 85 years or older
Corrao, G., Rea, F., Compagnoni, M. M., Merlino, L. G., & Mancia, G. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001323 · Cited by 46
Self-citationMakhele, L., Matlala, M., Sibanda, M., Martin, A. P., & Godman, B. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-0124-5 · Cited by 51
Erectile dysfunction and adherence to antihypertensive therapy: Focus on β-blockers
Manolis, A. J., Doumas, M. N., Ferri, C., & Mancia, G. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.009 · Cited by 49
Self-citationMancia, G., Parodi, A. F., Merlino, L. G., & Corrao, G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834550d0 · Cited by 47
Self-citationAntihypertensive Combination Treatment: State of the Art
Burnier, M. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0562-0 · Cited by 44
Adherencia terapéutica en la enfermedad crónica: estado de la situación y perspectiva de futuro
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.03.008 · Cited by 85
Medication persistence and the use of generic and brand-name blood pressure-lowering agents
Corrao, G., Soranna, D., Vecchia, C. L., Catapano, A. L., Agabiti‐Rosei, E., Gensini, G., Merlino, L. G., & Mancia, G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000130 · Cited by 41
Self-citationMancia, G., Schumacher, H., Böhm, M., Redón, J., Schmieder, R. E., Verdecchia, P., Sleight, P., Teo, K. K., & Yusuf, S. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09714 · Cited by 42
Self-citationDiagnosis and management of resistant hypertension: state of the art
Wei, F.-F., Zhang, Z.-Y., Huang, Q.-F., & Staessen, J. A. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0006-6 · Cited by 39
Corrao, G., Soranna, D., Merlino, L. G., & Mancia, G. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12326 · Cited by 45
Self-citationAcceptance of Illness and Compliance with Therapeutic Recommendations in Patients with Hypertension
Pluta, A., Sulikowska, B., Manitius, J., Posieczek, Z., Marzec, A., & Morisky, D. E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186789 · Cited by 41
Therapeutic strategies to improve control of hypertension
Armario, P., & Waeber, B. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835d2c6c · Cited by 40
Mourad, J., Amodeo, C., Champvallins, M. D., Brzozowska-Villatte, R., & Asmar, R. G. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001359 · Cited by 43
“The advantage of SPC formulations of antihypertensive agents over their corresponding free drug components is a significant 29% increase in compliance to treatment [13] and 26% increase in adherence over 1 year [14] achieving more effective BP control with reduced numbers of tablets [15,16] and reduced morbidity and m…”
BackgroundMedication Adherence and Incident Preventable Hospitalizations for Hypertension
Will, J. C., Zhang, Z., Ritchey, M. D., & Loustalot, F. V. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.08.021 · Cited by 41
Bruno, R. M., Taddei, S., Borghi, C., Colivicchi, F., Desideri, G., Grassi, G. M., Mazza, A., Muiesan, M. L., Parati, G., Pontremoli, R., et al. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00367-0 · Cited by 42
Hunnicutt, J. N., Ulbricht, C. M., Chrysanthopoulou, S. A., & Lapane, K. L. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4076 · Cited by 35
Mandini, S., Conconi, F., Mori, E., MYERS, J. N., Grazzi, G., & Mazzoni, G. (2018) · PeerJ · doi:10.7717/peerj.5471 · Cited by 40
“Regular physical activity reduces blood pressure and has been 28 recommended by American and the European hypertension guidelines (5, 6).”
BackgroundInfluentialAntihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database
Rea, F., Cantarutti, A., Merlino, L. G., Ungar, A., Corrao, G., & Mancia, G. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14683 · Cited by 35
“First, the investigation was based on a large unselected population, which was made possible because in Italy, a cost-free healthcare system extends to virtually all citizens who can thus be part of the database.(28,32,33,36) Second, the drug prescription database provides accurate data because pharmacists are require…”
MethodSelf-citationBurnier, M. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000045 · Cited by 34
Atthakomol, P., Manosroi, W., Phanphaisarn, A., Phrompaet, S., Iammatavee, S., & Tongprasert, S. (2018) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-018-1948-3 · Cited by 34
Adherence to Treatment by Initial Antihypertensive Mono and Combination Therapies
Rea, F., Savaré, L., Franchi, M., Corrao, G., & Mancia, G. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab083 · Cited by 40
Self-citationBurnier, M., Prejbisz, A., Weber, T., Azizi, M., Cunha, V. D. S., Versmissen, J., Gupta, P., Václavík, J., Januszewicz, A., Persu, A., et al. (2021) · Blood Pressure · doi:10.1080/08037051.2021.1963209 · Cited by 42
Rampamba, E. M., Meyer, J. C., Helberg, E. A., & Godman, B. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1356228 · Cited by 38
Treatment compliance in chronic illness: Current situation and future perspectives
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2014.03.003 · Cited by 38
Berhe, D. F., Taxis, K., Haaijer‐Ruskamp, F. M., Mulugeta, A., Mengistu, Y. T., & Mol, P. G. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015743 · Cited by 31
“34 The level of adherence we observed (40% and 57% for MMAS-8 with a cut-off at >6 and ≥ 6, respectively) was close to that reported by Asgedom et al (35% and 61%, respectively).”
ResultTung, Y., Lin, Y., Wu, L., Chang, C., & Chu, P. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12449 · Cited by 35
Williams, B., Masi, S., Wolf, J., & Schmieder, R. E. (2020) · Cardiology and Therapy · doi:10.1007/s40119-019-00159-1 · Cited by 33
Liu, M., Zheng, G., Cao, X., Chang, X., Zhang, N., Liang, G., Wang, A., Yu, Y. P., Yang, Y., Zhao, Y., et al. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110146 · Cited by 38
Metadata
- Authors
- Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G.
- Affiliations
- University of Milano-Bicocca (IT)
- University of Milan (IT)
- Regione Lombardia (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Corresponding author
- Corrao, Giovanni
- Venue
- Journal of Hypertension
- Published
- 2011-03
- Volume
- 29
- Issue
- 3
- Pages
- 610-618
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1970957826
- Cited by
- 367
- References
- 59
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 33 · 2023: 26 · 2022: 26 · 2021: 35 · 2020: 33 · 2019: 33 · 2018: 29 · 2017: 22 · 2016: 17 · 2015: 18 · 2014: 25 · 2013: 21 · 2012: 10
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- antihypertensive medication adherence, hypertension, cardiovascular risk, cardiovascular hospitalization, coronary disease, cerebrovascular disease, primary prevention, treatment persistence, proportion of days covered
- MeSH terms
- Adult, Aged, Antihypertensive Agents, Cardiovascular Diseases, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk, Cohort Studies, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.